When: May 29-31 on the NIH campus in Bethesda, Md.
The symposium will be videocast live and archived.
Symposium Location
National Institutes of Health
Natcher Conference Center, Building 45
Bethesda, MD 20892
The 7th Annual National Institutes of Health (NIH) Pain Consortium Symposium, Novel Approaches and Therapy Development for Pain Management, will be held in conjunction with a Food and Drug Administration workshop, Assessment of Analgesic Treatment of Chronic Pain.
The NIH Pain Consortium Symposium will focus on research advances related to therapy development of novel opioid analgesic formulations and approaches, novel nonopioid analgesic development and testing, and nonpharmacological strategies as adjuncts to pain management. Presentations will highlight NIH-funded studies that have made significant contributions to advancing the field of pain research. A poster session also will be part of the symposium and will include a broad selection of current pain research findings presented by talented young investigators. Members of the extramural scientific community, the NIH scientific community, health care providers, advocates, and the public are invited to attend. The event will be hosted by the chair, Dr. Story Landis, director of the National Institute of Neurological Disorders and Stroke, and the Executive Committee of the NIH Pain Consortium, including Dr. Josephine P. Briggs, director of the National Center for Complementary and Alternative Medicine; Dr. Patricia A. Grady, director of the National Institute of Nursing Research; Dr. Martha J. Somerman, director of the National Institute of Dental and Craniofacial Research; and Dr. Nora D. Volkow, director of the National Institute on Drug Abuse.
The public workshop, hosted by the FDA Center for Drug Evaluation and Research, will begin at 1 p.m. on May 30, immediately following the adjournment of the NIH Pain Consortium Symposium and will conclude on May 31 at 5 p.m. It will include a discussion of the available data on the efficacy of analgesics in the treatment of chronic noncancer pain (CNCP). The focus of the presentations and discussions by scientific experts and other stakeholder groups will be on the available clinical data from both randomized clinical trials and other studies of the efficacy of opioid analgesics, and comparison of that data to the data from studies of nonopioid analgesics used in the treatment of CNCP.